Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021

Cardiac amyloidosis is caused by the deposition of misfolded protein fibrils into the extracellular space of the heart. The diagnosis of cardiac amyloidosis remains challenging because of the heterogeneous manifestations of the disease. There are many different types of amyloidosis with light-chain...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostics (Basel) 2021-05, Vol.11 (6), p.996
Main Authors: Li, Weijia, Uppal, Dipan, Wang, Yu Chiang, Xu, Xiaobo, Kokkinidis, Damianos G., Travin, Mark I., Tauras, James M.
Format: Article
Language:English
Subjects:
Accuracy
Biopsy
cardiac amyloidosis
cardiac scintigraphy
Disease
Heart
positron emission tomography
Proteins
Retention
Review
Scintigraphy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiac amyloidosis is caused by the deposition of misfolded protein fibrils into the extracellular space of the heart. The diagnosis of cardiac amyloidosis remains challenging because of the heterogeneous manifestations of the disease. There are many different types of amyloidosis with light-chain (AL) amyloidosis and transthyretin (ATTR) amyloidosis being the most common types of cardiac amyloidosis. Endomyocardial biopsy is considered the gold standard for diagnosing cardiac amyloidosis and differentiating amyloid subtypes, but its use is limited because of the invasive nature of the procedure, with risks for complications and the need for specialized training and centers to perform the procedure. Radionuclide cardiac imaging has recently become the most commonly performed test for the diagnosis of ATTR amyloidosis but is of limited value for the diagnosis of AL amyloidosis. Positron emission tomography has been increasingly used for the diagnosis of cardiac amyloidosis and its applications are expected to expand in the future. Imaging protocols are under refinement to achieve better quantification of the disease burden and prediction of prognosis.
ISSN:2075-4418
2075-4418
DOI:10.3390/diagnostics11060996